Hargrove, Taylor

About

Dr. Taylor Hargrove is an Associate Professor of Sociology at the University of Maryland, College Park, and a faculty associate at the Maryland Population Research Center. Her research examines how racism and other systems of inequality become embodied and impact population health in the United States. Drawing on stratification, intersectionality, life course, biopsychosocial, and stress process perspectives, she employs advanced quantitative methods and analyzes longitudinal, nationally representative datasets spanning the life course from childhood to old age. Her current program of research investigates linkages among socio-geographic contexts, individual-level status characteristics, and biological measures of health and aging in young adulthood and early mid-life, aiming to clarify how macro- and meso-level environments shape downstream pathways that affect health outcomes. As a Multiple Principal Investigator on several externally funded studies, Dr. Hargrove has contributed significantly to data infrastructure by linking novel contextual data to existing population-based longitudinal datasets. She has led efforts to build comprehensive data repositories featuring repeated, multilevel measures of structural racism and other demographic, socioeconomic, health, and mobility characteristics at various geographic levels. Additionally, she helped develop a key biological dataset containing inflammatory and immune markers typically unavailable in population studies. Her work…

Research topics

• Medicine
• Internal medicine
• Oncology
• Urology
• Biology
• Physics
• Immunology

Selected publications

• Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

  The Lancet Oncology · 2023 · 81 citations

  BACKGROUND: Temporary drug treatment cessation might alleviate toxicity without substantially compromising efficacy in patients with cancer. We aimed to determine if a tyrosine kinase inhibitor drug-free interval strategy was non-inferior to a conventional continuation strategy for first-line treatment of advanced clear cell renal cell carcinoma. METHODS: This open-label, non-inferiority, randomised, controlled, phase 2/3 trial was done at 60 hospital sites in the UK. Eligible patients (aged ≥18…

  PublisherOA PDFDOI

• Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

  The Lancet · 2024 · 46 citations

  BACKGROUND: Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after radical prostatectomy is unclear. METHODS: RADICALS-HD was an international randomised controlled trial to test the efficacy of ADT used in combination with postoperative radiotherapy for prostate ca…

  DOI

• Fiber Optic Sensors Based upon the Fabry–Perot Interferometer

  2017-12-19 · 26 citations

  book-chapter1st authorCorresponding

  The Fabry–Perot interferometer (FPI), sometimes called the Fabry–Perot etalon, consists of two mirrors of reflectance R 1 and R 2 separated by a cavity 36of length L, as in Figure 2.1. Since its invention in the late 19th century [1], the bulk-optics version of the FPI has been widely used for high-resolution spectroscopy. In the early 1980s, the first results on fiber optic versions of the FPI were reported. In the late 1980s, fiber Fabry–Perot interferometers began to be applied to the sensing…

  PublisherDOI

• Correspondence of Henry Taylor

  2006-07-09 · 12 citations

  book1st authorCorresponding
  Publisher

• Fiber Optic Sensors Based upon the Fabry‚ÄìPerot Interferometer

  Optical science and engineering · 2008-03-27 · 2 citations

  book-chapter1st authorCorresponding
  PublisherDOI

Frequent coauthors

• Janet Forkes

  Centre Hospitalier Universitaire de Sherbrooke

  15 shared

• Chung Eun Lee

  Gyeongsang National University Hospital

  14 shared

• Robert A. Atkins

  Texas A&M University

  12 shared

• O. Eknoyan

  Texas A&M University

  11 shared

• Janet Ryan-Smith

  Mount Vernon Cancer Centre

  10 shared

• Ananya Choudhury

  The Christie NHS Foundation Trust

  9 shared

• Noel W. Clarke

  The Christie NHS Foundation Trust

  8 shared

• William N. Gibler

  Texas A&M University

  7 shared

Similar researchers at University of Maryland, College Park

• Doan, Longh-8
• Presser, Stanleyh-3